title: The STAMPEDE trial and celecoxib: how to adapt?
authors.affiliation: Duke Cancer Institute and Duke Prostate Center, Duke University Medical Center, Durham, NC, USA. andrew.armstrong@duke.edu
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Armstrong
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068579:Celecoxib; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib